首页> 外文期刊>国际肝胆胰疾病杂志(英文版) >Combined serum hepatoma-speciifc alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma
【24h】

Combined serum hepatoma-speciifc alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma

机译:血清特异性肝癌特异性甲胎蛋白和循环甲胎蛋白-mRNA联合诊断肝细胞癌

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide, its prognosis is poor, and early detection is of utmost importance. Although alpha-fetoprotein (AFP) is a useful marker for detecting and monitoring HCC development, the false-negative or false-positive rates with AFP alone may be as high as 30%-40%for patients with small HCCs. To enhance the speciifcity and accuracy of AFP measurements for HCC, we analyzed AFP expression states in livers, detected the hepatoma-speciifc AFP (HS-AFP) fraction and AFP-mRNA from peripheral blood mononuclear cells, and explored their clinical implications for HCC diagnosis. METHODS:AFP expression and hepatocyte distributions in liver specimens were investigated by an immunohistoche-mical assay. Total RNAs were extracted from circulating blood, synthesized to cDNA through random primers and reverse transcriptase, and fragments of the AFP gene were ampliifed by a nested-PCR assay. The HS-AFP fraction was separated by lectin-afifnity chromatography and its level was detected by radioimmunoassay. RESULTS: The incidence of AFP was 73.3% in HCC tissues and its expression in HCCs with moderate or low differentiation was signiifcantly stronger than that of HCCs with high differentiation (P<0.05). The incidence of AFP gene fragments was 100% in HCCs, and 60% in paracancerous tissues (P<0.01). In the HCC and liver cirrhosis groups, the incidence of HS-AFP was 91.7%and 18% (P<0.01), and of AFP-mRNA was 56.7% and 16%(P<0.01), respectively, and neither was found in controls. HS-AFP or AFP-mRNA was not signiifcantly related to size or number of HCC, but to its differentiation, metastasis, and relapse (P<0.05). CONCLUSIONS: Different AFP expression is present in different parts of HCC tissues. HS-AFP and AFP-mRNA fragments improve sensitivity and speciifcity, and both are useful markers to diagnose HCC or monitor metastasis and relapse.
机译:背景:肝细胞癌(HCC)是全世界最常见的恶性肿瘤之一,其预后较差,早期发现至关重要。尽管甲胎蛋白(AFP)是检测和监测肝癌发展的有用标志物,但对于小肝癌患者,单独使用AFP的假阴性或假阳性率可能高达30%-40%。为了提高肝癌AFP检测的特异性和准确性,我们分析了肝脏中AFP的表达状态,检测了外周血单核细胞中的肝癌特异性AFP(HS-AFP)部分和AFP-mRNA,并探讨了其对HCC诊断的临床意义。 方法:采用免疫组织化学方法检测肝脏标本中AFP的表达和肝细胞的分布。从循环血液中提取总RNA,通过随机引物和逆转录酶合成为cDNA,并通过巢式PCR分析扩增AFP基因的片段。通过凝集素亲和色谱法分离HS-AFP级分,并通过放射免疫测定法检测其水平。 结果:肝癌组织中AFP的发生率为73.3%,其在中分化程度低的肝癌中的表达明显强于分化程度高的HCC(P <0.05)。在肝癌中AFP基因片段的发生率为100%,在癌旁组织中为60%(P <0.01)。在肝癌和肝硬化组中,HS-AFP的发生率分别为91.7%和18%(P <0.01),AFP-mRNA的发生率分别为56.7%和16%(P <0.01),而在HCC和肝硬化组中均未发现控制。 HS-AFP或AFP-mRNA与HCC的大小或数量无显着相关,但与其分化,转移和复发密切相关(P <0.05)。 结论:肝癌组织的不同部位存在不同的AFP表达。 HS-AFP和AFP-mRNA片段可提高敏感性和特异性,两者都是诊断HCC或监测转移和复发的有用标志物。

著录项

  • 来源
    《国际肝胆胰疾病杂志(英文版)》 |2006年第004期|538-544|共7页
  • 作者单位

    Research Center of Clinical Molecular Biology, Afifliated Hospital of Nantong University, Nantong 226001, China Wu W, Yao DF, Yuan YM, Fan JW, Lu XF, Li XH, Qiu LW, Zong L and Wu XH;

    Research Center of Clinical Molecular Biology, Afifliated Hospital of Nantong University, Nantong 226001, China Wu W, Yao DF, Yuan YM, Fan JW, Lu XF, Li XH, Qiu LW, Zong L and Wu XH;

    Research Center of Clinical Molecular Biology, Afifliated Hospital of Nantong University, Nantong 226001, China Wu W, Yao DF, Yuan YM, Fan JW, Lu XF, Li XH, Qiu LW, Zong L and Wu XH;

    Research Center of Clinical Molecular Biology, Afifliated Hospital of Nantong University, Nantong 226001, China Wu W, Yao DF, Yuan YM, Fan JW, Lu XF, Li XH, Qiu LW, Zong L and Wu XH;

    Research Center of Clinical Molecular Biology, Afifliated Hospital of Nantong University, Nantong 226001, China Wu W, Yao DF, Yuan YM, Fan JW, Lu XF, Li XH, Qiu LW, Zong L and Wu XH;

    Research Center of Clinical Molecular Biology, Afifliated Hospital of Nantong University, Nantong 226001, China Wu W, Yao DF, Yuan YM, Fan JW, Lu XF, Li XH, Qiu LW, Zong L and Wu XH;

    Research Center of Clinical Molecular Biology, Afifliated Hospital of Nantong University, Nantong 226001, China Wu W, Yao DF, Yuan YM, Fan JW, Lu XF, Li XH, Qiu LW, Zong L and Wu XH;

    Research Center of Clinical Molecular Biology, Afifliated Hospital of Nantong University, Nantong 226001, China Wu W, Yao DF, Yuan YM, Fan JW, Lu XF, Li XH, Qiu LW, Zong L and Wu XH;

    Research Center of Clinical Molecular Biology, Afifliated Hospital of Nantong University, Nantong 226001, China Wu W, Yao DF, Yuan YM, Fan JW, Lu XF, Li XH, Qiu LW, Zong L and Wu XH;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:39:25
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号